ILMN Stock Gains Following Expanded Collaboration With Labcorp

Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth ...

Illumina advances preventive genomics through strategic consortium with Veritas Genetics

Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration with Veritas Genetics Powered By Fuze Health to form a consortium that aims to bring preventive genomics into everyday ...
Insider Monkey

Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other immunotherapy ...

Illumina, Inc.: Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded ...
Hosted on MSN

Does Illumina (ILMN) Have Good Long-Term Growth Prospects?

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” investor letter for the first quarter of 2025. A copy of the letter can be downloaded here. The first quarter of ...
Pharmabiz

Illumina and Labcorp expand collaboration to advance precision oncology through innovative applications of NGS solutions

Illumina and Labcorp expand collaboration to advance precision oncology through innovative applications of NGS solutions: San Diego Friday, March 20, 2026, 15:00 Hrs [IST] Illumin ...
Insider Monkey

Why Illumina, Inc. (ILMN) Is Plunging So Far In 2025

We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the ...
Business Wire

Illumina, Inc. (ILMN) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Illumina, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. (NASDAQ: ...
Benzinga.com

Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit

Illumina Inc. (NASDAQ:ILMN) has agreed to pay $9.8 million to resolve allegations it knowingly sold genomic sequencing systems with cybersecurity vulnerabilities to several U.S. government agencies.
Law

Element Biosciences, Inc. v. Illumina, Inc.

Illumina Inc. was hit with an antitrust lawsuit on Sept. 22 in California Northern District Court over alleged anticompetitive practices in the DNA sequencing market. The action, brought by Quinn ...

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology ...